1,399.00
+4.50
+(0.32%)
At close: 3:45:01 PM GMT+9
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Total Revenue
97,772,000.00
94,461,000.00
94,921,000.00
93,080,000.00
99,371,000.00
Cost of Revenue
50,599,000.00
49,008,000.00
50,087,000.00
49,008,000.00
49,450,000.00
Gross Profit
47,172,000.00
45,452,000.00
44,834,000.00
44,072,000.00
49,921,000.00
Operating Expense
37,135,000.00
34,726,000.00
32,638,000.00
30,735,000.00
34,605,000.00
Operating Income
10,037,000.00
10,726,000.00
12,196,000.00
13,337,000.00
15,316,000.00
Net Non Operating Interest Income Expense
241,000.00
158,000.00
88,000.00
100,000.00
124,000.00
Pretax Income
10,184,000.00
11,154,000.00
13,143,000.00
13,531,000.00
15,836,000.00
Tax Provision
3,614,000.00
3,592,000.00
4,381,000.00
4,552,000.00
4,976,000.00
Net Income Common Stockholders
6,431,000.00
7,423,000.00
8,581,000.00
8,785,000.00
10,643,000.00
Diluted NI Available to Com Stockholders
6,431,000.00
7,423,000.00
8,581,000.00
8,785,000.00
10,643,000.00
Basic EPS
53.78
62.06
71.72
73.44
88.93
Diluted EPS
53.78
62.06
71.72
73.44
88.93
Basic Average Shares
119,589.43
119,617.08
119,651.57
119,635.53
119,675.45
Diluted Average Shares
119,589.62
119,617.08
119,651.57
119,635.53
119,675.45
Total Operating Income as Reported
10,037,000.00
10,726,000.00
12,195,000.00
13,336,000.00
15,316,000.00
Total Expenses
87,734,000.00
83,734,000.00
82,725,000.00
79,743,000.00
84,055,000.00
Net Income from Continuing & Discontinued Operation
6,431,000.00
7,423,000.00
8,581,000.00
8,785,000.00
10,643,000.00
Normalized Income
6,852,269.64
7,671,826.00
8,795,107.00
9,526,688.00
10,831,650.00
Interest Income
323,000.00
256,000.00
182,000.00
179,000.00
156,000.00
Interest Expense
82,000.00
98,000.00
94,000.00
79,000.00
32,000.00
Net Interest Income
241,000.00
158,000.00
88,000.00
100,000.00
124,000.00
EBIT
10,266,000.00
11,252,000.00
13,237,000.00
13,610,000.00
15,868,000.00
EBITDA
15,274,000.00
16,331,000.00
18,184,000.00
17,771,000.00
19,840,000.00
Reconciled Cost of Revenue
50,599,000.00
49,008,000.00
50,087,000.00
49,008,000.00
49,450,000.00
Reconciled Depreciation
5,008,000.00
5,079,000.00
4,947,000.00
4,161,000.00
3,972,000.00
Net Income from Continuing Operation Net Minority Interest
6,431,000.00
7,423,000.00
8,581,000.00
8,785,000.00
10,643,000.00
Total Unusual Items Excluding Goodwill
-653,000.00
-367,000.00
-321,000.00
-1,117,000.00
-275,000.00
Total Unusual Items
-653,000.00
-367,000.00
-321,000.00
-1,117,000.00
-275,000.00
Normalized EBITDA
15,927,000.00
16,698,000.00
18,505,000.00
18,888,000.00
20,115,000.00
Tax Rate for Calcs
0.00
0.00
0.00
0.00
0.00
Tax Effect of Unusual Items
-231,730.36
-118,174.00
-106,893.00
-375,312.00
-86,350.00
12/31/2020 - 1/4/2001
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
4967.T Kobayashi Pharmaceutical Co., Ltd.
5,763.00
+1.71%
4922.T KOSÉ Corporation
6,737.00
+2.29%
8113.T Unicharm Corporation
1,217.50
+0.12%
4452.T Kao Corporation
5,847.00
+0.27%
4911.T Shiseido Company, Limited
2,595.00
+3.51%
1044.HK HENGAN INT'L
20.900
+0.48%
PZC.L PZ Cussons plc
80.60
+2.68%
OR.PA L'Oréal S.A.
343.45
+1.34%
CLX The Clorox Company
160.78
+0.19%
PG The Procter & Gamble Company
161.31
+0.50%